Non Invasive Diabetes Therapy Market Analysis
The major factor that hinders growth of the global interventional neurology market include high cost of neurovascular surgical procedures and devices. For instance, according to an article published by the MAMC Journal of Medical Sciences, in March 2018, the cost of endovascular coiling of a cerebral aneurysm is usually determined by the number of catheters and coils utilized during the procedure. Studies showed a relatively higher cost of admission for endovascular coiling as compared to open surgery with regard to a comparable cerebral aneurysm. As a result, endovascular intervention is not always more cost effective than open surgery.
๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐๐ฒ๐ฟ๐ฒ ๐๐ผ๐ฟ ๐๐ต๐ฒ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฝ๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ @ https://www.coherentmarketinsights.com/insight/request-sample/54
The non-invasive therapy market is attracting both established players and new entrants who are looking to capitalize on its potential and generate high returns on investment. As a result, the market is projected to experience a double-digit growth rate during the forecast period.
The analysis in the report encompasses different regions, namely Europe, North America, Latin America, Asia Pacific, the Middle East, and Africa.
Market Dynamics:
According to the World Health Organization, the number of people with diabetes is expected to reach 336 million by 2030, up from 270 million in 2015. This rise in diabetes cases is likely to increase the demand for non-invasive therapies and create a positive market environment for industry players. Furthermore, advancements in healthcare access and increased investment in research and development could contribute to the growth of the non-invasive therapy market. Some companies are also developing non-invasive systems using photonic technology and occlusion spectroscopy technology.
The market for non-invasive therapy is expected to experience further growth due to evolving macroeconomic factors and shifting consumer preferences. Developing regions have witnessed an increase in healthcare expenditure, leading to a larger consumer base for non-invasive therapy. These factors, along with changes in lifestyle, are expected to create significant market opportunities for early adopters.
Regional Analysis:
Throughout the forecast period, the market is expected to be dominated by North America, which is projected to grow at a rapid pace due to high investments in research and development, as well as the presence of major companies in the region. The region also has a higher prevalence of diabetes compared to other regions.
According to an initial study by CA, North America and Europe are projected to comprise more than 65% of the overall functional non-invasive diabetes therapy market. This technology is being sought by healthcare providers to address the growing demand for diabetes management. In addition, macroeconomic factors are expected to drive growth in these regions. The two regions collectively allocate over 5% of their GDP on research and development. Furthermore, healthcare spending is the highest in these regions, with North America accounting for 16.7% and Europe accounting for 10% of the overall GDP in 2015.
The growth of the non-invasive diabetes therapy market in Asia Pacific is expected to be primarily driven by China and India. The International Diabetes Federation estimates that over 490 million people in China are suffering from diabetes, and the country is pushing for healthcare reforms. This has led to the emergence of many companies in the region, which is expected to create favorable market opportunities.
๐๐ฎ๐ฒ ๐๐จ๐ฐ, ๐๐๐ญ๐ญ๐ข๐ง๐ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ (๐๐ฉ ๐๐จ ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ) ๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ @ https://www.coherentmarketinsights.com/promo/buynow/54
Competition Landscape:
Several major companies are operating in the non-invasive therapy market, including B. Braun Melsungen, DexCom, ACON Laboratories, Bayer, Calisto Medical, Bio Tex, and others.
Key Developments
The non-invasive diabetes therapy market is anticipated to witness growth driven by ongoing research and development activities. A new hormone injection was tested by a team of researchers in August 2019, which could potentially assist weight loss in diabetic patients who are obese. This could be a non-invasive option to gastric bypass surgery, which is commonly used to manage weight and improve blood sugar levels in individuals with diabetes.
In addition, leading companies in the non-invasive diabetes therapy market are actively engaging in strategic collaborations and partnerships to enhance their market position. For example, in July 2019, BioRestorative Therapies, Inc. announced a securities purchase agreement with Arena Investors LP. BioRestorative Therapies, Inc. develops non-invasive therapeutic solutions utilizing cell and tissue protocols, with a particular focus on its ThermoStem program aimed at reducing obesity and diabetes risk.
The University of Michigan revealed in July 2019 its plans for a clinical trial of EndoBarrier, a new non-invasive, endoscopic weight-loss procedure developed by GI Dynamicsยฎ Inc. The study will involve individuals with type 2 diabetes and obesity.
Table of Content
Global Non Invasive Diabetes Therapy Market Research Report
Section 1: Global Non Invasive Diabetes Therapy Industry Overview
Section 2: Global Economic Impact on Non Invasive Diabetes Therapy Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Non Invasive Diabetes Therapy Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Non Invasive Diabetes Therapy Market Forecast
๐๐ฒ๐ ๐๐ผ๐๐ฟ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฒ๐ฑ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ @ https://www.coherentmarketinsights.com/insight/request-customization/54
Explore More Reports:
High intensity focused ultrasound hifu marketย
Advanced wound care management market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email:ย sales@coherentmarketinsights.com
Phone:ย U.S.: +1-206-701-6702
U.K.:ย +44-020-8133-4027
JAPAN:ย +81-50-5539-1737
INDIA:ย +91-848-285-0837